Cat. No.: DMM-001288
Status | Age | Sex |
---|---|---|
|
|
|
Model Overview | |
---|---|
Model Description | This Liastm1Mae mutant allele has the exons 4-6 of the of the lipoic acid synthetase (Lias) gene deleted. The deleted region encodes the functionally conserved Cys motifs of the enzyme responsible for converting octanoic acid to α-lipoic acid (also called 1,2-dithiolane-3-pentanoic acid, thioctic acid, ALA, or LA). These Lias mutant mice may be useful in studying α-lipoic acid requirements during development, mitochondrial dysfunction, and oxidative stress-related diseases such as diabetes, atherosclerosis, and neurodegenerative disorders. |
Strain Name | 129S6/SvEv-Liastm1Mae/J |
Background Strain | 129S6 / SvEv |
SPF | Yes |
Research Application | Diabetes |
Target Information | |
---|---|
Target Name | LIAS |
Synonyms | 2900022L22Rik, 4933425M12Rik, 7a5ex, HGCLAS, HUSSY-01, LAS, LIP1, LS, MGC7254, mLip1, PDHLD |
Gene ID | 11019 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.